Skip to content
Himalaya Nutravedics India logo

Himalaya Nutravedics India

544943 BSE
₹116.00

Close ·

View as Markdown
MCP
Close 4 Nov 2026 ₹116.00 −6.90 −5.61% since 29 Sep 2026
Start ₹122.90

Key Fundamentals

SME

Price-based figures at the close · TTM

ROCE
52.20%
Debt to Equity
0.31
EPS (TTM)
—
Book Value
₹48.69
Market Cap
—
P/E (TTM)
—
P/B
2.38
ROE
63.90%
Dividend Yield
0.00%
EBITDA
₹8.20 Cr
52W High
₹167.20
52W Low
₹111.00

Key Insights

Strengths

1
  • Company has a good return on equity (ROE) track record: 3 Years ROE 59.8%

Weaknesses

1
  • Working capital days have increased from 69.7 days to 105 days

Technical Indicators

Technical signals: verdict and indicator counts
GroupSignalBearishNeutralBullish
OverallBearish5131
OscillatorsNeutral171
Moving AveragesBearish460

Key readings

RSI (14)
46.21
Neutral
MACD (12,26,9)
—
Neutral
SMA (50)
—
Neutral
SMA (200)
—
Neutral

As of

Growth Rate

From the financial statements below. 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025.

Revenue

Revenue growth by window
3Y+175.91%
1Y+105.05%

Net profit

Net profit growth by window
3Y+266.59%
1Y+231.39%

Operating cash flow

Operating cash flow growth by window
3Y—
1YOutflow widened by ₹2.44 Cr

3Y: The statements do not go back far enough for this window.

Operating margin· change in pp

Operating margin growth by window
3Y+5.17 pp
1Y+4.59 pp

Trailing twelve months: No quarterly results are reported.

Revenue by year

Revenue by year, ₹ crore
Mar 2023₹2.05 Cr
Mar 2024₹14.43 Cr
Mar 2025₹21.00 Cr
Mar 2026₹43.06 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2023₹0.15 Cr
Mar 2024₹0.43 Cr
Mar 2025₹2.23 Cr
Mar 2026₹7.39 Cr

Profit & Loss

₹ Cr
544943 profit and loss, annual, ₹ crore
Particulars Mar 2023Mar 2024Mar 2025Mar 2026
Sales
2.05
14.43
21
43.06
Expenses
1.77
13.49
18.01
34.95
Operating Profit
0.28
0.94
2.99
8.11
OPM %
13.66%
6.51%
14.24%
18.83%
Other Income
0
0
0
0.05
Interest
0.02
0.18
0.32
0.35
Depreciation
0.06
0.16
0.42
0.33
PBT
0.2
0.6
2.25
7.48
Tax %
25%
28.33%
0.89%
1.2%
Net Profit
0.15
0.43
2.23
7.39
EPS (₹)
1.25
3.58
3.72
11.72
Div. Payout %
0%
0%
0%
0%

Balance Sheet

₹ Cr
544943 balance sheet, annual, ₹ crore
Particulars Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
0.83
0.83
4
6.31
Reserves
0.15
0.53
2.76
10.07
Borrowings
1.32
3.24
1.76
5.13
Other Liabilities
0.93
1.49
2.3
2.91
Total Liabilities
3.23
6.09
10.82
24.42
Fixed Assets
0.58
1.5
1.29
1.03
CWIP
0
0
0
0
Investments
0
0.02
0.03
0.07
Other Assets
2.65
4.57
9.5
23.32
Total Assets
3.23
6.09
10.82
24.42

Cash Flow

₹ Cr
544943 cash flow, annual, ₹ crore
Particulars Mar 2023Mar 2024Mar 2025Mar 2026
Operating
—
−0.55
−1.39
−3.83
Investing
—
−1.1
−0.23
−0.06
Financing
—
1.84
1.44
5.27
Net Cash Flow
—
0.19
−0.18
1.38
Free Cash Flow
—
−1.63
−1.6
−3.9
CFO/EBITDA
—
−40
−46
−46

Ratios

544943 financial ratios, annual
Particulars Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
169
39.21
98.03
89.77
Inventory Days
736
112
96.55
143
Days Payable
60.83
27.56
37.68
11.2
Cash Conversion Cycle
844
124
157
221
Working Capital Days
296
6.58
97.85
105
ROCE %
—
22.61%
39.18%
52.15%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Himalaya Nutravedics India insights

39 extracted metrics across FY23–FY26.

Shareholding Pattern

As of Sep 2026

  • Promoters 68.13%
  • Public 13.98%
  • Others 10.90%
  • FIIs 6.99%

No promoter shares pledged as of 14 Oct 2026

Change vs previous quarter

Documents

Frequently Asked Questions about Himalaya Nutravedics India

What does Himalaya Nutravedics India Ltd do?
Incorporated in June 2022, Himalaya Nutravedics India Limited is engaged in the manufacturing, marketing, and distribution of Ayurvedic and nutraceutical formulations.
Where is Himalaya Nutravedics India Ltd (HNIL) listed?
Himalaya Nutravedics India Ltd trades under code 544943 on the BSE.
Which sector does Himalaya Nutravedics India Ltd belong to?
Himalaya Nutravedics India Ltd is classified under the Healthcare sector, in the Pharmaceuticals & Biotechnology industry.
What is the 52-week high and low of Himalaya Nutravedics India Ltd?
Over the last 52 weeks Himalaya Nutravedics India Ltd has traded between ₹111 and ₹167.2 as of 4 Nov 2026.
What is the Return on Equity (ROE) of Himalaya Nutravedics India Ltd?
Himalaya Nutravedics India Ltd reported a return on equity of 63.90%. Its debt-to-equity ratio is 0.31.

Company Information

Incorporated in June 2022, Himalaya Nutravedics India Limited is engaged in the manufacturing, marketing, and distribution of Ayurvedic and nutraceutical formulations.

Face Value ₹10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/544943.md for Himalaya Nutravedics India Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month